Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Post by OptGreenon Apr 15, 2024 12:15pm
162 Views
Post# 35989559

Very Nice!!

Very Nice!!Canopy is there finally and there is still a long way to go for the industry and the company, of which is where the investment in Canopy et al should carry a healthy edge with Klein in on the ground floor already both sides of the 49th and plenty of contact/ ground work off shore as well.
Canopy et al need to be up and runing along with a large percentage of the legal cannabis production in the US on the shelf to fill the void left by cartel bud and fentanyl, as the clean up progresses. Legal cannabis is going to save the US, Canada and many more already there or soon will be...just with fentanyl clean up alone will probably be in the millions saved quick as this is a global issue if not dealt with in NA asap?
The US operations in place now will be producing plenty of bud and just as access to off shore markets begin to open...it will not surprise to see cannabis based product being much more readily acceptable as the broader group of folks that will choose cannabis than a lot of the pharma chemical based product out there today? I find it the best for arthritis. There is plenty to be learned and gained from cannabis as it is researched and tested.
Everybody needs to do their DD and buy, sell or hold accordingly. JMHO...Opt

Canopy Growth to expedite entry into U.S. cannabis market (msn.com)
6 Diseases That Can Be Treated with Medical Marijuana (msn.com)
Medical Marijuana Sector to Witness Tremendous Growth, Predicted Worth of USD 30 Billion by 2032 - PharmiWeb.com
Pakistan Launches Regulatory Body For Cannabis Trade To Fuel Economic Growth (msn.com)
Medical marijuana laws and mental health in the United States | Health Economics, Policy and Law | Cambridge Core
<< Previous
Bullboard Posts
Next >>